BDX Stock Summary and Trading Ideas (Becton Dickinson And Company | NYSE:BDX)

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 24% of revenue. International revenue accounts for 43% of the company's business.

Becton Dickinson And Company trades on the NYSE stock market under the symbol BDX.

As of February 3, 2023, BDX stock price declined to $245.84 with 1,574,090 million shares trading.

BDX has a beta of 0.70, meaning it tends to be less sensitive to market movements. BDX has a correlation of 0.40 to the broad based SPY ETF.

BDX has a market cap of $69.88 billion. This is considered a Large Cap stock.

Last quarter Becton Dickinson And Company reported $5 billion in Revenue and $2.98 earnings per share. This beat revenue expectation by $66 million and exceeded earnings estimates by $.30.

In the last 3 years, BDX stock traded as high as $286.72 and as low as $197.75.

The top ETF exchange traded funds that BDX belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.

BDX has underperformed the market in the last year with a price return of -7.8% while the SPY ETF lost -6.3%. However, in the short term, BDX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +11.7% vs +11.6% return in SPY. But in the last 2 weeks, BDX shares have been beat by the market, returning -3.1% compared to an SPY return of +4.2%.

BDX support price is $245.20 and resistance is $251.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDX stock will trade within this expected range on the day.